Case-control study found higher β2-microglobulin levels in diabetics than non-diabetics, suggesting cadmium influences clearance rates.
Beta-2-microglobulin (β₂M) is released into plasma from nucleated cells, filtered by glomeruli, and degraded by proximal tubular cells (PTCs). Normally, < 1% of filtered β₂M is excreted in urine. Intoxication of PTCs by cadmium (Cd) reduces degradation and increases excretion of β₂M (TDβ2M and Eβ2M). Diabetes may exacerbate these effects or produce them independently. Herein, we normalized fluxes to creatinine clearance (Ccr) to quantify amounts of β₂M excreted and degraded per volume of filtrate (Eβ2M/Ccr and TDβ2M/Ccr). We then performed a case-control study of diabetics (DM, n = 65) and non-diabetics (CTRL, n = 72) with modest Cd exposure. β₂M influx (Iβ2M, equated with β₂M filtration rate), serum β₂M ([β₂M]s), and TDβ2M/Ccr were higher in DM. Fractional tubular degradation of filtered β₂M (FrTDβ2M) emerged as the least confounded descriptor of PT β₂M processing, and low values of FrTDβ2M were seen in a subset of diabetics with minimal Cd intoxication. FrTDβ2M varied inversely with ECd/Ccr in DM and directly with estimated GFR (eGFR) in DM and CTRL. In both groups, Eβ2M/Ccr was inversely related to eGFR and FrTDβ2M, but at any value of FrTDβ2M, Eβ2M/Ccr varied by a large multiple. We conclude that in subjects with modest Cd intoxication, Iβ2M was variable in DM and CTRL and higher in DM; FrTDβ2M was related inversely to ECd/Ccr in DM and directly to eGFR in DM and CTRL; and Eβ2M/Ccr varied inversely with eGFR and FrTDβ2M in both groups. Eβ2M/Ccr did not depict FrTDβ2M precisely. We recommend FrTDβ2M as an indicator of proximal tubular dysfunction.
No takes yet. Share an insight, caveat, or question.
Phelps et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: